Calithera Biosciences, Inc. (CALA) Social Stream
CALITHERA BIOSCIENCES INC (CALA) Price Targets From Analysts
Use the tables below to see what analysts covering CALITHERA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $1.5 | $1 | $1.25 | $0.03 | 4066.67% |
| 2022-01-20 | 4 | $3 | $1.5 | $2.25 | $0.03 | 7400% |
| 2022-02-09 | 4 | $4 | $1.5 | $2.833 | $0.03 | 9343.33% |
| 2022-04-01 | 4 | $3 | $1.5 | $2.5 | $0.03 | 8233.33% |
| 2022-05-10 | 4 | $3 | $1.5 | $2.166 | $0.03 | 7120% |
| 2022-05-11 | 4 | $40 | $30 | $33.333 | $0.03 | 111010% |
| 2022-08-16 | 4 | $30 | $18 | $26 | $0.03 | 86566.67% |
| 2022-08-18 | 4 | $30 | $17 | $21.666 | $0.03 | 72120% |
| 2022-08-29 | 4 | $30 | $8 | $18.25 | $0.03 | 60733.33% |
| 2022-11-15 | 4 | $18 | $8 | $13 | $0.03 | 43233.33% |
| NA | 1 | $NA | $NA | $NA | $0.03 | NA% |
The Trend in the Analyst Price Target
CALA's average price target has moved up $8 over the prior 21 months.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
CALA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CALA's average broker recommendation rating worsened by 0.33 over the prior 43 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CALA as an investment opportunity.
- In terms of how CALITHERA BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1797.27% of that group.
- CALA has a greater number of analysts covering the stock than 218.04% of all US stocks.
- CALA has a higher average analyst price target than 452.26% of stocks in the small market cap category.
- In terms of how CALITHERA BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -594.46% of that group.
Stocks similar to CALITHERA BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RLMD, NEPT, and AGLE.
View All Top Stocks by Price Target
Is CALA a Buy, Hold or Sell? See the POWR Ratings now!